CVE-2023-42666

Exposure of Sensitive Information to an Unauthorized Actor in DEXMA DEXGate

Description

The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability, which may allow an attacker to create malicious requests for obtaining the information of the version about the web server used.

Category

5.3
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.20%
Third-Party Advisory cisa.gov
Affected: DEXMA DexGate
Published at:
Updated at:

References

Link Tags
https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02 third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2023-42666?
CVE-2023-42666 has been scored as a medium severity vulnerability.
How to fix CVE-2023-42666?
To fix CVE-2023-42666, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-42666 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-42666 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-42666?
CVE-2023-42666 affects DEXMA DexGate.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.